Skip to main content
Equibles

CITIGROUP INC

Position in VCEL — Vericel Corp

CIK 831001 NEW YORK, NY
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$2,603,777
+$2,130,043 QoQ
Shares Held
58,525
+297.4% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. VCEL ranks #96 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 706,968 $351,172,214
2 REGN
Regeneron Pharmaceuticals, Inc.
 346,637 $216,142,034
3 MRNA
Moderna, Inc.
 2,165,414 $151,643,941
4 ROIV
Roivant Sciences Ltd.
 2,225,190 $78,749,472
5 ALNY
Alnylam Pharmaceuticals, Inc.
 227,786 $68,570,419
6 INCY
Incyte Corp
 586,431 $66,477,817
7 BBIO
BridgeBio Pharma, Inc.
 864,101 $64,358,241
8 RVMD
Revolution Medicines, Inc.
 247,052 $46,267,897

All Filings in VCEL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,603,777 58,525
2026-03-31 $473,734 14,726
2025-12-31 $777,526 21,592
2025-09-30 $1,505,492 47,839
2025-06-30 $3,677,764 86,434
2025-03-31 $4,913,374 110,116
2024-12-31 $4,945,028 90,057
2024-09-30 $2,739,785 64,847
2024-06-30 $2,050,698 44,697
2024-03-31 $9,235,005 177,528
2023-12-31 $2,459,047 69,055
2023-09-30 $2,389,003 71,271
2023-06-30 $2,249,278 59,869
2023-03-31 $3,207,343 109,391
2022-12-31 $2,773,680 105,303
2022-09-30 $3,591,080 154,788
2022-06-30 $3,125,315 124,119
2022-03-31 $2,474,209 64,736
2021-12-31 $5,510,134 140,207
2021-09-30 $3,238,123 66,355
2021-06-30 $5,139,224 97,890
2021-03-31 $5,757,479 103,645
2020-12-31 $510,600 16,535
2020-09-30 $1,489,977 80,409
2020-06-30 $608,066 43,999
2020-03-31 $343,369 37,445